期刊文献+

罗格列酮钠片溶出度的测定方法

The Method for the Dissolution Test of Rosiglitazone Sodium Tablets
下载PDF
导出
摘要 采用紫外分光光度法测定罗格列酮钠片的溶出度。检测波长234nm。转速50r·min-1,溶出介质为0.01mol/L盐酸500mL;罗格列酮钠在(4~20)μg·mL-1-范围内线性良好,r=0.9999(n=7),方法平均回收率99.95%(n=9),日内和日间RSD分别为0.49%及0.75%。20min定时取样测定,主药溶出95%以上。方法简便、准确,可有效的控制其质量。 To determine the dissolution of Rosiglitazone Sodium Tablet, a UV-spectrophotometric method was used to study the dissolution with the detection wavelength at 234 rim. The rotative velocity of 50r·min^-1 and the 500 mL of water. The linear range of the standard curve was(4-20)μg·mL^-1, r=0.999 9(n=7). The average recovery of this method was 99.95%(n=9), the within-day RSD and between-day RSD were 0.49% and 0.75% respectively. The drug dissolution rate for 20min was over 95%. This method is convenient, accurate.
出处 《科学技术与工程》 2006年第2期238-239,241,共3页 Science Technology and Engineering
关键词 罗格列酮钠片 溶出度测定 平均回收率 Rosiglitazone Sodium Tablets dissolution determination average recovery
  • 相关文献

参考文献4

  • 1[1]Reaven G M.Banting lecture 1988.Role of insulin resistance in human disease.Diabetes,1988,37(12):1595 被引量:1
  • 2[2]Reiusser J,Auwerk J,Vidal H.Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49563) in human adipocytes.Biochem Biophys Res Commun,1999; 265 (1):265 被引量:1
  • 3[3]Cantello B C,Cawthorone M A.The synthesis of BRL-49653-A novel and potent antihyperglycaemic agent.Bioorg Mad.Chem Lett,1994;4(10):1181-1184 被引量:1
  • 4龚正华,黄世杰,张中启,袁莉,龚晓霞,沈伽弟,李玉凤,宫泽辉.罗格列酮钠在2种糖尿病动物模型上的降糖作用[J].中国新药杂志,2004,13(8):707-709. 被引量:6

二级参考文献7

  • 1[2]Tominaga M,Igarashi M,Daimon M,et al.Thiazolidindiones(AD-4833 and CS-045 improve hepatic insulin resistance in streptozotoin-induced diabetic rats[J].Endocrine J,1993,40(3):343-349. 被引量:1
  • 2[3]Katsumata K.Effect of a single administration of tolbutamide on the occurrence of alloxan diabetes[J].Horm Metabol Res,1990,22(3):192-193. 被引量:1
  • 3[4]Fujita T,Sugiyama Y,Taketomi S,et al.Reduction of insulin resistance in obese and or diabetic animals by 5-[4-(1-methycyclohexylmethoxy)-benzyl]- thiazolidine-2,4-dione(ADD-3878,U-63,287,Ciglitazone),a new antidiabetic agent[J].Diabetes,1983,32(9):804-810. 被引量:1
  • 4[5]Connor SC,Hughes MG,Moore G,et al.Antidiabetic efficacy of BRL 49653,a potent orally active insulin sensitizing agent,assessed in the C57L/KsJ db/db diabetic mouse by non-invasive 1H NMR studies of urine[J].J Pharm Pharmacol,1997,49(3):336-344. 被引量:1
  • 5[6]Barman Balfour JA,Plosker GL.Rosiglitazone[J].Drugs,1999 57(6):921-930. 被引量:1
  • 6[7]Oakes ND,Kennedy CJ,Jenkins AB,et al.A new antidiabetic agent,BRL 49653 reduces lipid availability and improves insulin action and glucoregulation in the rat[J].Diabetes,1994,43(10):1203-1210. 被引量:1
  • 7沈素.文迪雅[J].中国新药杂志,2001,10(5):382-383. 被引量:9

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部